Jianghong Cai

592 total citations · 1 hit paper
16 papers, 362 citations indexed

About

Jianghong Cai is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jianghong Cai has authored 16 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jianghong Cai's work include Boron Compounds in Chemistry (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Jianghong Cai is often cited by papers focused on Boron Compounds in Chemistry (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Jianghong Cai collaborates with scholars based in Macao, China and United States. Jianghong Cai's co-authors include Yi Zhun Zhu, Wei Hu, Qian Ding, Ran Wang, Peter Rose, Meng Li, Qinyan Yang, Menglin Zhu, Hong Ji and Zhaohua Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Molecules.

In The Last Decade

Jianghong Cai

15 papers receiving 358 citations

Hit Papers

Signaling pathways in rheumatoid arthritis: implications ... 2023 2026 2024 2025 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianghong Cai Macao 7 127 100 63 58 48 16 362
Qingshou Chen United States 12 90 0.7× 36 0.4× 113 1.8× 39 0.7× 62 1.3× 15 386
Vagelis Rinotas Greece 12 287 2.3× 49 0.5× 27 0.4× 64 1.1× 129 2.7× 29 438
Urszula Grabowska United Kingdom 14 286 2.3× 132 1.3× 170 2.7× 32 0.6× 152 3.2× 44 600
Kazuhiro Nagahira Japan 14 199 1.6× 23 0.2× 77 1.2× 174 3.0× 66 1.4× 26 485
Jordi Beleta Spain 7 104 0.8× 24 0.2× 151 2.4× 118 2.0× 75 1.6× 7 447
Paweł Krzysztof Halik Poland 8 146 1.1× 13 0.1× 36 0.6× 27 0.5× 76 1.6× 16 378
Nicole Bacher Austria 11 202 1.6× 37 0.4× 30 0.5× 183 3.2× 127 2.6× 14 510
Adolph E. Sloboda United States 9 76 0.6× 74 0.7× 72 1.1× 62 1.1× 76 1.6× 15 345
Vincenzo Giansanti Italy 10 260 2.0× 24 0.2× 28 0.4× 42 0.7× 92 1.9× 15 435
Tsuyoshi Yamanaka Japan 14 133 1.0× 45 0.5× 9 0.1× 15 0.3× 48 1.0× 34 427

Countries citing papers authored by Jianghong Cai

Since Specialization
Citations

This map shows the geographic impact of Jianghong Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianghong Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianghong Cai more than expected).

Fields of papers citing papers by Jianghong Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianghong Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianghong Cai. The network helps show where Jianghong Cai may publish in the future.

Co-authorship network of co-authors of Jianghong Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Jianghong Cai. A scholar is included among the top collaborators of Jianghong Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianghong Cai. Jianghong Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhang, Fuyuan, Jianghong Cai, Zhongxiao Lin, et al.. (2025). A novel molecule ZYZ311 derivatized from Carvacrol ameliorates DSS-induced colitis in mice via inhibiting JAK2/STAT3. International Immunopharmacology. 168(Pt 1). 115763–115763.
2.
Cai, Jianghong, Jiajie Liang, Jiahui Lin, et al.. (2024). Design, synthesis and mechanism study of coumarin-sulfonamide derivatives as carbonic anhydrase IX inhibitors with anticancer activity. Chemico-Biological Interactions. 393. 110947–110947. 5 indexed citations
3.
Zhang, Ying‐Jun, Jianghong Cai, Narayan S. Hosmane, & Yinghuai Zhu. (2024). In silico assessments of the small molecular boron agents to pave the way for artificial intelligence-based boron neutron capture therapy. European Journal of Medicinal Chemistry. 279. 116841–116841. 5 indexed citations
4.
Ding, Qian, Jianghong Cai, Jin Li, et al.. (2024). A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter. SHILAP Revista de lepidopterología. 5(10). e711–e711. 3 indexed citations
5.
Lin, Zhongxiao, Jianghong Cai, Quan Zheng, et al.. (2023). Discovery of deoxyandrographolide and its novel effect on vascular senescence by targeting HDAC1. SHILAP Revista de lepidopterología. 4(5). e338–e338. 1 indexed citations
6.
Ding, Qian, Song Wu, Yue Yu, et al.. (2023). Hydrogen Sulfide and Functional Therapy: Novel Mechanisms from Epigenetics. Antioxidants and Redox Signaling. 40(1-3). 110–121. 4 indexed citations
7.
Ding, Qian, Wei Hu, Ran Wang, et al.. (2023). Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduction and Targeted Therapy. 8(1). 68–68. 244 indexed citations breakdown →
8.
Cai, Jianghong, Jiajie Liang, Jiahui Lin, et al.. (2023). Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay. Frontiers in Pharmacology. 14. 1141121–1141121. 11 indexed citations
9.
Hu, Wei, Qian Ding, Jianghong Cai, et al.. (2022). Update of Indoles: Promising molecules for ameliorating metabolic diseases. Biomedicine & Pharmacotherapy. 150. 112957–112957. 29 indexed citations
10.
Lin, Zhongxiao, Xiaoyan Liu, Qian Ding, et al.. (2022). HDAC4 Inhibitors as Antivascular Senescence Therapeutics. Oxidative Medicine and Cellular Longevity. 2022(1). 3087916–3087916. 6 indexed citations
11.
Wang, Ran, Meng Li, Qian Ding, et al.. (2021). Neuron navigator 2 is a novel mediator of rheumatoid arthritis. Cellular and Molecular Immunology. 18(9). 2288–2289. 6 indexed citations
12.
Zhu, Yinghuai, Jianghong Cai, Narayan S. Hosmane, et al.. (2021). Carboxyboranylamino ethanol: unprecedented discovery of boron agents for neutron capture therapy in cancer treatment. Chemical Communications. 57(79). 10174–10177. 5 indexed citations
13.
Zhu, Yinghuai, et al.. (2020). Synthesis, reactivity,in vitroboron neutron capture therapy assay, and molecular docking of fluorocyclocarboxyboranylamine. Applied Organometallic Chemistry. 34(8). 1 indexed citations
14.
Cai, Jianghong, Narayan S. Hosmane, Masao Takagaki, & Yinghuai Zhu. (2020). Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine. Molecules. 25(20). 4697–4697. 10 indexed citations
15.
Ji, Hong, et al.. (2018). Room-temperature borylation and one-pot two-step borylation/Suzuki–Miyaura cross-coupling reaction of aryl chlorides. RSC Advances. 8(25). 13643–13648. 22 indexed citations
16.
Ji, Hong, Jianghong Cai, Zhaohua Wang, et al.. (2018). Palladium-catalyzed borylation of aryl (pseudo)halides and its applications in biaryl synthesis. Chemistry Central Journal. 12(1). 136–136. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026